MENU
ROIV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Roivant Sciences (ROIV) Ownership - Who owns Roivant Sciences?
Profile
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.84B
P/E Ratio
2.19
Total Cash
5.39B
Projected Growth
N/A
Total Debt
52.71M
Revenue
129.13M
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash/Share
7.40
Total Debt/Equity
N/A
Revenue/Share
0.16 USD as % of share price
Fundamentals
ROIV
Capitalization
8.85B
P/E Ratio
2.19
Risk (Beta)
1.52
Dividend Yield
N/A
Total Cash
5.39B
Total Cash/Share
7.40
Total Debt
52.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.16%
Revenue
129M
ROE
N/A
Book Value
5.15B
P/B Ratio
1.72
Cash Flow
N/A
Earnings
6.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
10.43
Current Revenue Per Employee
4928.41
Dividends Per Share - Security
N/A
EBITDA
4.15B
Float
N/A
Float - Current
N/A
Gross Income Margin
94.77
Revenue To Assets
116.31
Shares Held By Institutions
12B
Shares Outstanding - Current
728M
Total Liabilities
626M
Total Volume MTD
N/A
Value
N/A
Gain YTD
8.192
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
50 Broadway
Phone
+44 2074003347
Employees
904
Web
N/A